Vantage Consulting Group’s Repligen RGEN Stock Holding History

Vantage Consulting Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-55	Closed	-$11K	–	1233
2020 Q4	$11K	Buy	+55	New	+$10K	﹤0.01%	1155

Other funds holding RGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vantage Consulting Group's RGEN Position: Q1 2021 in Review

Vantage Consulting Group sold out of Repligen (RGEN) in Q1 2021, closing a stake of 55 shares — an estimated $11K sold.

Vantage Consulting Group first reported a position in RGEN in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

Vantage Consulting Group reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 55 Repligen shares in Q1 2021, an estimated $11K.
Vantage Consulting Group first reported a position in Repligen in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Repligen position peaked at $11K in Q4 2020.
458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.